Evidence map›Paper›PMID 18625204›Full record

ArticleBiochemical and biophysical research communications2008

Dissecting the regulation of yeast genes by the osmotin receptor.

Brian R Kupchak, Nancy Y Villa, Lidia V Kulemina, Thomas J Lyons

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. ROS Dependent Antifungal and Anticancer Modulations ofMolecules (Basel, Switzerland) · 2021
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brian R KupchakDepartment of Chemistry, University of Florida, P.O. Box 117200, Gainesville, FL 32611, USA.
Nancy Y Villa
Lidia V Kulemina
Thomas J Lyons

Funding

Probing the mechanisms of signal transduction via adiponectin and its receptorsR21DK074812 · NIDDK · UNIVERSITY OF FLORIDA · PI LYONS, THOMAS J · 2006 to 2007
$260k
NIDDK NIH HHS R21 DK074812
6 · The paper itself

Abstract

The Izh2p protein from Saccharomyces cerevisiae is a receptor for the plant antifungal protein, osmotin. Since Izh2p is conserved in fungi, understanding its biochemical function could inspire novel strategies for the prevention of fungal growth. However, it has been difficult to determine the exact role of Izh2p because it has pleiotropic effects on cellular biochemistry. Herein, we demonstrate that Izh2p negatively regulates functionally divergent genes through a CCCTC promoter motif. Moreover, we show that Izh2p-dependent promoters containing this motif are regulated by the Nrg1p/Nrg2p and Msn2p/Msn4p transcription factors. The fact that Izh2p can regulate gene expression through this widely dispersed element presents a reasonable explanation of its pleiotropy. The involvement of Nrg1p/Nrgp2 in Izh2p-dependent gene regulation also suggests a role for this receptor in regulating fungal differentiation in response to stimuli produced by plants.

Indexed as

Gene Expression Regulation, FungalResponse ElementsBase SequenceCation Transport ProteinsDNA-Binding ProteinsMembrane ProteinsPlant ProteinsRepressor ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTranscription FactorsCation Transport ProteinsDNA-Binding ProteinsIZH2 protein, S cerevisiaeMembrane ProteinsMSN2 protein, S cerevisiaeMSN4 protein, S cerevisiaeNRG1 protein, S cerevisiaeNrg2 protein, S cerevisiaePlant ProteinsRepressor ProteinsSaccharomyces cerevisiae ProteinsTranscription FactorsZRT1 protein, S cerevisiae

Identifiers

PMID18625204
PMCPMC2537462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.